| Protein | Regulatory-associated protein of mTOR (RPTOR, Raptor) |
|---|---|
| Encoded by | [RPTOR](/genes/rptor) |
| Primary complex | mTOR complex 1 (mTORC1) |
| Core role | Scaffold/adaptor for nutrient-sensitive kinase signaling |
| Key disease links | [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), [Huntington's disease](/diseases/huntingtons-disease) |
RPTOR (Raptor) is the substrate-recruitment and signaling scaffold that defines mTORC1 specificity.[1][2] In neurons, RPTOR integrates nutrient, growth-factor, and energy-state inputs to control protein synthesis, autophagy suppression, and lysosome-coupled anabolic tone.[3][4]
RPTOR is a large HEAT/armadillo-repeat-rich scaffold that binds mTOR and substrate motifs, positioning effectors such as S6K and 4E-BP proteins for phosphorylation.[1:1][2:1] AMPK-dependent phosphorylation of RPTOR can enforce a metabolic checkpoint under energy stress, lowering mTORC1 drive.[5]
In healthy brain tissue, RPTOR-containing mTORC1 supports synaptic protein translation, axonal/dendritic growth programs, and activity-adaptive plasticity. This function must remain tightly balanced with autophagic flux to avoid proteostatic overload in long-lived neurons.[3:1][6]
Hyperactive RPTOR-mTORC1 signaling has been linked to reduced autophagy and accumulation of toxic protein assemblies in multiple neurodegenerative settings.[4:1][7] Conversely, excessive mTORC1 suppression can impair repair and plasticity, so disease-relevant biology is usually a network-level imbalance rather than simple on/off behavior.[3:2][8]
Human genetics now also implicates RPTOR in neurodegenerative risk architecture, supporting translational interest in mTORC1 node precision rather than blanket inhibition.[9]
Current intervention logic focuses on modulating the RPTOR-mTORC1 axis with context-specific intensity:
Hara K, Maruki Y, Long X, et al. [Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action](https://doi.org/10.1016/S0092-8674(02). Cell. 2002. ↩︎ ↩︎
Kim DH, Sarbassov DD, Ali SM, et al. [mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery](https://doi.org/10.1016/S1097-2765(02). Mol Cell. 2002. ↩︎ ↩︎
Saxton RA, Sabatini DM. mTOR Signaling in Growth, Metabolism, and Disease. Cell. 2017. ↩︎ ↩︎ ↩︎
Ravikumar B, Vacher C, Berger Z, et al. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet. 2004. ↩︎ ↩︎
Gwinn DM, Shackelford DB, Egan DF, et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell. 2008. ↩︎ ↩︎
Tramutola A, Lanzillotta C, Perluigi M, Butterfield DA. Oxidative stress, protein modification and Alzheimer disease. Front Aging Neurosci. 2018. ↩︎
Caccamo A, Majumder S, Richardson A, Strong R, Oddo S. Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau. J Neurosci. 2010. ↩︎ ↩︎
Bové J, Martínez-Vicente M, Vila M. Fighting neurodegeneration with rapamycin. Trends Neurosci. 2011. ↩︎ ↩︎
Fan L, Wang H, Xu Y, et al. RPTOR Is an Alzheimer's Disease Susceptibility Gene Associated with the Risk Factors Body Mass Index and Infectious Encephalitis. J Alzheimers Dis. 2024. ↩︎
Malagelada C, Jin ZH, Greene LA. Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease. J Neurosci. 2010. ↩︎